LUCID GROUP INC (LCID)

US5494981039 - Common Stock

2.46  +0.01 (+0.41%)

After market: 2.45 -0.01 (-0.41%)

Fundamental Rating

3

Overall LCID gets a fundamental rating of 3 out of 10. We evaluated LCID against 40 industry peers in the Automobiles industry. While LCID seems to be doing ok healthwise, there are quite some concerns on its profitability. LCID is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

LCID had negative earnings in the past year.
In the past year LCID has reported a negative cash flow from operations.
In the past 5 years LCID always reported negative net income.
LCID had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -33.23%, LCID is doing worse than 63.16% of the companies in the same industry.
Looking at the Return On Equity, with a value of -58.30%, LCID is in line with its industry, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
ROA -33.23%
ROE -58.3%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-44.54%
ROE(3y)-79.52%
ROE(5y)-71.61%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LCID does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
LCID has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LCID has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.35, we must say that LCID is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.35, LCID perfoms like the industry average, outperforming 44.74% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that LCID is not too dependend on debt financing.
LCID has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: LCID outperforms 44.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z -1.35
ROIC/WACCN/A
WACC11.64%

2.3 Liquidity

LCID has a Current Ratio of 4.72. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
LCID's Current ratio of 4.72 is amongst the best of the industry. LCID outperforms 86.84% of its industry peers.
A Quick Ratio of 4.03 indicates that LCID has no problem at all paying its short term obligations.
LCID's Quick ratio of 4.03 is amongst the best of the industry. LCID outperforms 92.11% of its industry peers.
Industry RankSector Rank
Current Ratio 4.72
Quick Ratio 4.03

5

3. Growth

3.1 Past

LCID shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.65%.
Looking at the last year, LCID shows a decrease in Revenue. The Revenue has decreased by -2.13% in the last year.
LCID shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 429.93% yearly.
EPS 1Y (TTM)-3.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q30.23%
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y429.93%
Revenue growth 5YN/A
Revenue growth Q2Q-39.02%

3.2 Future

The Earnings Per Share is expected to grow by 16.16% on average over the next years. This is quite good.
Based on estimates for the next years, LCID will show a very strong growth in Revenue. The Revenue will grow by 81.48% on average per year.
EPS Next Y21.08%
EPS Next 2Y11.78%
EPS Next 3Y16.38%
EPS Next 5Y16.16%
Revenue Next Year32.65%
Revenue Next 2Y82.66%
Revenue Next 3Y91.86%
Revenue Next 5Y81.48%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

LCID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

LCID's earnings are expected to grow with 16.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.78%
EPS Next 3Y16.38%

0

5. Dividend

5.1 Amount

LCID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LUCID GROUP INC

NASDAQ:LCID (4/26/2024, 7:00:45 PM)

After market: 2.45 -0.01 (-0.41%)

2.46

+0.01 (+0.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.66B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.23%
ROE -58.3%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.72
Quick Ratio 4.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y429.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y